DrugPatentWatch Database Preview

NOVOLOG MIX 70/30 Drug Profile

« Back to Dashboard

Summary for Tradename: NOVOLOG MIX 70/30

Patents:	12
Applicants:	1
BLAs:	1
Suppliers: see list	3
Recent Clinical Trials:	See clinical trials for NOVOLOG MIX 70/30
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for NOVOLOG MIX 70/30

Recent Clinical Trials for NOVOLOG MIX 70/30

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Arecor Limited	Phase 1
The Cleveland Clinic	Phase 4
Boston Medical Center	Phase 3

See all NOVOLOG MIX 70/30 clinical trials

Recent Litigation for NOVOLOG MIX 70/30

Identify key patents and potential future biosimilar entrants

District Court Litigation

Case Name	Date
SANOFI-AVENTIS U.S. LLC v. MYLAN N v.	2017-10-24
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.	2017-03-03
Novo Nordisk Inc. v. Teva Pharmaceuticals USA, Inc.	2017-03-02

See all NOVOLOG MIX 70/30 litigation

Company Disclosures: US Patents for NOVOLOG MIX 70/30

These patents were extracted from company disclosures

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Novo Nordisk Inc	NOVOLOG MIX 70/30	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021172	001	2002-05-03		Novo Nordisk A/S (Basgsvaerd, DK)	2013-08-20	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 70/30	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021172	001	2002-05-03		Novo Nordisk A/S (Bagsvaerd, DK)	2014-04-08	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 70/30	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021172	001	2002-05-03		Novo Nordisk A/S (Bagsvaerd, DK)	2014-12-02	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 70/30	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021172	001	2002-05-03		Novo Nordisk A/S (Bagsvaerd, DK)	2013-06-21	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 70/30	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021172	001	2002-05-03		Novo Nordisk A/S (Bagsvaerd, DK)	2013-06-21	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 70/30	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021172	001	2002-05-03		Novo Nordisk A/S (Bagsvaerd, DK)	2016-06-20	DISCN		company
Novo Nordisk Inc	NOVOLOG MIX 70/30	insulin aspart protamine recombinant; insulin aspart recombinant	INJECTABLE;SUBCUTANEOUS	021172	001	2002-05-03		Novo Nordisk A/S (Bagsvaerd, DK)	2018-01-30	DISCN		company

International Patents for NOVOLOG MIX 70/30

Country	Patent Number	Estimated Expiration
Denmark	1003581
Japan	H06500939
Ireland	66138
Austria	208208
Denmark	395685
Australia	8544191
Portugal	1003581

Supplementary Protection Certificates for NOVOLOG MIX 70/30

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
132006901385693	Italy		PRODUCT NAME: SOSPENSIONE CONTENENTE INSULINA ASPART SOLUBILE E CRISTALLI DI INSULINA ASPART PROTAMINATA NEL RAPPORTO 70/30(NOVOMIX 70); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/00/142/017-018-019-020-021-022, 20051005
40/2005	Austria		PRODUCT NAME: NOVOMIX 50 - SUSPENSION, ENTHALTEND LOESLICHES INSULIN ASPART UND PROTAMINKRISTALLISIERTES INSULIN ASPART IM VERHAELTNIS 50:50; REGISTRATION NO/DATE: EU/1/00/142/011 - EU/1/00/142/016 20051005
CA 2005 00047	Denmark		PRODUCT NAME: INSULIN ASPART, PROTAMINKRYSTALLISERET
32/2000	Austria		PRODUCT NAME: INSULIN ASPART/PROTAMIN; NAT. REGISTRATION NO/DATE: EU/1/00/142/001-008 20000801; FIRST REGISTRATION: LI 55414-55416 20000623
SZ 50/1999	Austria		PRODUCT NAME: INSULIN ASPART
99C0044	Belgium		PRODUCT NAME: INSULIN-ASPART; NAT. REGISTRATION NO/DATE: EU/1/99/119/001 19990907; FIRST REGISTRATION: CH 55045 01 19990615
SPC/GB99/045	United Kingdom		SPC/GB99/045: 20060829, EXPIRES: 20110828